Description

Crestor (rosuvastatin) Coated Tablets 20 mg. №28

Ingredients:

Each tablet contains 20 mg of rosuvastatin as the active ingredient.

Dosage:

The recommended dosage is one 20 mg tablet per day. It is important to follow the instructions provided by your healthcare provider.

Indications:

Crestor tablets are indicated for the treatment of high cholesterol and triglycerides. They are used in conjunction with a healthy diet and exercise to help lower the risk of heart disease.

Contraindications:

Do not take Crestor if you are pregnant or breastfeeding, have liver disease, or are allergic to rosuvastatin. It is important to discuss any medical conditions with your doctor before starting this medication.

Directions:

Take one tablet orally with water, with or without food, at the same time each day. Do not crush or chew the tablet. Follow your doctor’s instructions carefully.

Scientific Evidence:

Studies have shown that rosuvastatin, the active ingredient in Crestor, is highly effective in lowering LDL cholesterol levels and reducing the risk of cardiovascular events. Research published in the New England Journal of Medicine demonstrated the superior efficacy of rosuvastatin compared to other statins in reducing cholesterol levels.

Additional Information:

It is important to regularly monitor your cholesterol levels while taking Crestor and to report any unusual symptoms to your healthcare provider. This medication should be used as part of a comprehensive treatment plan that includes lifestyle changes.

Rosuvastatin works by inhibiting HMG-CoA reductase, an enzyme involved in the production of cholesterol in the liver. By lowering cholesterol levels, Crestor helps reduce the risk of atherosclerosis and cardiovascular disease.

Crestor has been shown to be more effective in lowering LDL cholesterol and raising HDL cholesterol compared to other statins. Clinical trials have demonstrated its ability to significantly reduce the incidence of heart attacks, strokes, and other cardiovascular events in high-risk patients.